PM-Scl antibodies are found in patients with homogenous overlap connective tissue disease characterized by Raynaud’s phenomenon, scleroderma, myositis, arthritis and pulmonary restriction. The presence of PM-Scl autoantibodies is a good prognostic sign unlike the poor prognosis seen with other myositis and systemic sclerosis-specific antibodies.
3 - 5 days
- Polymyositis Associated Antibody
- PM-1 Antibody
- Anti-PM/Scl Ab
Collect specimen in an SST tube. Centrifuge, aliquot serum into a plastic vial and refrigerate within one hour of collection.
Collect specimen in an SST or red top tube. Spin and aliquot within one hour or collection. Send to Specimen Processing refrigerated
Specimen must be spun, aliquotted and refrigerated within one hour of collection.
Test sent to Labcorp Dublin; performed by Esoterix Endocrinology